Presentation is loading. Please wait.

Presentation is loading. Please wait.

FLUOROQUINOLONES: FROM STRUCTURE TO ACTIVITY AND TOXICITY.

Similar presentations


Presentation on theme: "FLUOROQUINOLONES: FROM STRUCTURE TO ACTIVITY AND TOXICITY."— Presentation transcript:

1 FLUOROQUINOLONES: FROM STRUCTURE TO ACTIVITY AND TOXICITY

2 CONTENTS: 1.INTRODUCTION 2.MECHANISM OF ACTION 3.CHEMISTRY AND ACTIVITY 4.TOXICITY 5.SAR 6.PHARMACOKINETICS 7.DRUG INTERACTIONS.

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21 SYNTHESIS OF NALIDIXIC ACID:

22 Ciprofloxacin Administration [Usual Dosage]: IV.
Spectrum: Gram- aerobic rods, and Legionella pneumophila, and other atypicals. Poor activity against Strep. pneumoniae. Indications: -- Nosocomial pneumonia -- Intra-abdominal infections Uncomplicated/complicated UTI Anthrax exposure and prophylaxis Unique Qualities: Binds divalent cations (i.e. Ca & Mg) which decreases absorption -- Increased effects of warfarin ADRs QTC prolongation, torsades de pointes, arrhythmias Nausea, GI upset Interstitial nephritis Not inclusive list of indications; patients at risk for tendon effects (>60 yo, renal failure, dialysis, concomitant corticosteroid therapy, dyslipidemia); weakest quinolone against MSSA

23 SYNTHESIS OF CIPROFLOXACIN:

24 CIPROFLOXACIN SYNTHESIS ( Cont):

25

26

27

28

29 STRUCTURE OF SPARFLOXACIN :

30 SYNTHESIS OF SPARFLOXACIN:

31 SYNTHESIS OF SPARFLOXACIN (Cont):

32

33 STRUCTURE OF TROVAFLOXACIN:

34

35

36

37

38

39

40

41

42

43

44 TOXICITY ASSOCIATED WITH FLUOROQUINOLONES
GI: nausea, vomiting, diarrhea, abdominal pain CNS: dizziness, sleep disturbance, confusion, seizure Liver: hepatitis, liver failure Kidney: hematuria, crystalluria, nephritis, renal failure Musculoskeletal: tendinitis, arthropathy, tendon rupture Cardiovascular: hypotension, tachycardia with QTc changes Skin: rash, pruritis, photosensitivity Endocrine: disturbance in glucose homeostasis

45

46

47 SAR of Quinolones 1,4-dihydro-4-oxo-3-pyridinecarboxylic acid portion is necessary for the antibacterial activity. The pyridone ring must be attached to an aromatic ring, in which isosteric substitution of carbon with nitrogen still remaines the activity.

48 SAR continued... Isosteric substitution of carbon with nitrogen still remains the activity.

49 SAR continued... N1-Substitution is necessary for antibacterial activity. Small alkyl or cycloalkyl groups increase it: cyclopropyl>ethyl>methyl

50 SAR continued... Substitution at C2 position decreases the activity remarkably or changes the antibacterial characters. Substitution at C5 , C6 , C7 and especially at C8 has good effects on the activity. C6 fluorine substitution increases the activity prominently, That’s why quinolones are also called fluoroquinolones. Substituted or unsubstituted piperazinyl or pyrolidinyl groups at C7 increase the activity against p.aeroginosa

51 SAR continued... Ring fusion at C1and C8; C5 and C6; C6 and C7 or C7and C8 introduces active compounds:

52 Why Fluoroquinolones cause CNS toxicity?
Tremor, sleep disorders, anxiety, and convulsions because of GABA antagonism at the receptor. Because of low penetration to brain this toxicity is rare.

53

54 How Fluoroquinolones cause metal comlexation?
This occurs with cations such as Ca2+, Zn2+, Fe2+, Fe3+, Bi3+. That’s why there is an interaction between quinolones and mineral containing drugs. Since this complexes are water insoluble, and there are bivalent metal ions in the urine, fluoroquinolones cause crystalluria.

55

56

57

58

59

60

61

62 Fluoroquinolone Drug Interactions: Ciprofloxacin and Levofloxacin
Ciprofloxacin listed 36 different drug interactions Levofloxacin listed 11 drug interactions

63 Ciprofloxacin as the perpetrator drug
Mechanism Drug CYP1A2 inhibition caffeine, clozapine, mexiletine, olanzapine, R-warfarin, rasagiline, ropinirole, ropivacaine, theophylline, tizanidine, duloxetine, zolmitriptan CYP3A4 inhibition cyclophosphamide, sildenafil, glyburide, cyclosporine Inhibition of organic ion transporters methotrexate, probenecid, procainamide, cimetidine Reduced enterohepatic recycling Ethinyl estradiol Lack of interaction Diazepam, ethanol Unknown isoniazid

64 Levofloxacin as the perpetrator drug
Mechanism Drug Inhibition of organic ion transporters cimetidine, procainamide Lack of interaction digoxin, oxycodone, theophylline, AZT Unknown Cyclosporine, tacrolimus

65 Common interactions with both drugs
Mechanism Drug Complexation of drug to fluoroquinolone antacids, iron salts, calcium salts, magnesium salts, zinc oxide, didanosine Disruption of normal gut flora warfarin Unknown Antidiabetics, NSAIDs, probenecid

66 FLUOROQUINOLONES (In development )
METABOLISM: Most fluoroquinolones are metabolized in the liver and excreted in urine, reaching high levels in urine. Moxifloxacin (AVELOX) is eliminated primarily in bile. FLUOROQUINOLONES (In development ) garenoxacin (Geninax) (Application withdrawn due to toxicity issues) delafloxacin

67 CONCLUSION

68 References 1.PPT by F.VAN BAMBEKE & P.M .TULKENS . ( 2.Wikipedia. Ciprofloxacin January 2009 < 3. Synthesis of drugs from SURENDRA N.PANDEEYA (Vol :II) .

69 THANK U


Download ppt "FLUOROQUINOLONES: FROM STRUCTURE TO ACTIVITY AND TOXICITY."

Similar presentations


Ads by Google